<--- Back to Details
First PageDocument Content
Mantoux test / Latent tuberculosis / Tuberculin / Type IV hypersensitivity / Immunosuppressive drug / Drug injection / Heaf test / QuantiFERON / Tuberculosis / Medicine / Health
Mantoux test
Latent tuberculosis
Tuberculin
Type IV hypersensitivity
Immunosuppressive drug
Drug injection
Heaf test
QuantiFERON
Tuberculosis
Medicine
Health

sanofi pasteur[removed]TUBERSOL® 1 2

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 220,55 KB

Share Document on Facebook

Similar Documents

Laboratoire de Bactériologie  BACT-R2-MOPE-011 Prélèvement pour le test QuantiFERON®-TB Plus Rédigé par : F. SCHRAMM

Laboratoire de Bactériologie BACT-R2-MOPE-011 Prélèvement pour le test QuantiFERON®-TB Plus Rédigé par : F. SCHRAMM

DocID: 1vpC1 - View Document

Microsoft Word - ACHA_Tuberculosis_Screening_Apr2014

Microsoft Word - ACHA_Tuberculosis_Screening_Apr2014

DocID: 1qCot - View Document

Student Health Center 501 Student Health Irvine, CAwww.shc.uci.edu  Incoming Student Health FormAcademic Year

Student Health Center 501 Student Health Irvine, CAwww.shc.uci.edu Incoming Student Health FormAcademic Year

DocID: 1qwnS - View Document

TB & TB Testing Frequently Asked Questions 1. Why are there different measurements for the tuberculin skin test (TST)? a. The classification is based on the person’s risk of being infected with TB and progression to di

TB & TB Testing Frequently Asked Questions 1. Why are there different measurements for the tuberculin skin test (TST)? a. The classification is based on the person’s risk of being infected with TB and progression to di

DocID: 1qtiG - View Document

NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas Farley, MD, MPH Commissioner  July 30, 2012

NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE Thomas Farley, MD, MPH Commissioner July 30, 2012

DocID: 1qlpQ - View Document